Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial
Published Online: 2021-01-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Akira Shimizu•Hirofumi Mukai•Hiroji Iwata•Hironori Haga•Hiroshi Ishiguro•Kenjiro Aogi•Kenjiro Jimbo•Masahiro Kitada•Masahiro Takada•Masakazu Toi•Nobuaki Sato•Norikazu Masuda•Shigehira Saji•Shigeru Imoto•Shinji Ohno•Takafumi Ikeda•Takanori Ishida•Takayuki Kinoshita•Takayuki Ueno•Tomoharu Sugie•Toshiaki Saeki•Yasuo Ohashi•Yasuyuki Sato•Yoshinori Ito•Yuichiro Kai
